Skip to content
OpenCapital
Get started

Veracyte VCYT Free cash flow yield

Free cash flow yield at other companies

Guardant Health logo
Guardant HealthGH
-2%-0.8pp
Natera, Inc. logo
Natera, Inc.NTRA
0.4%-0.1pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
4.7%-0.5pp
Revvity logo
RevvityRVTY
5%+0.9pp
Labcorp Holdings logo
Labcorp HoldingsLH
6.3%+0.4pp
Quest Diagnostics logo
Quest DiagnosticsDGX
6.2%+0.5pp

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0×0.0×
Current ratio9.3×+4.2×

Where this comes from

Calculated from Veracyte’s reported figures.

free cash flow/market cap=6.1%

Based on trailing twelve months.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's free cash flow yield?
Veracyte (VCYT) reported free cash flow yield of 6.1% in Q1 2026.
How has Veracyte's free cash flow yield changed year-over-year?
Veracyte's free cash flow yield increased by 78.8% year-over-year, from 3.4% to 6.1%.
What is the long-term trend for Veracyte's free cash flow yield?
Over 2 years (2023 to 2025), Veracyte's free cash flow yield has grown at a 49.5% compound annual growth rate (CAGR), from 1.7% to 3.8%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.